Press Releases : Promoting Greater Transparency in Prescription Drug Pricing

AG Platkin, Division of Consumer Affairs Announce New Rules Aimed at Promoting Greater Transparency in Prescription Drug Pricing, Including How and Why Prices Are Increased

Oct 16, 2024 | Adopted New Rules | DCA | Division of Consumer Affairs | Drug Affordability Council | drug supply chain | emerging trends in drug pricing | How and Why Prices Are Increased | insurance carriers | manufacturers | pharmacy benefits managers | pharmacy services administrative organizations | Prescription Drug Prices | Promoting Greater Transparency in Prescription Drug Pricing | regulatory policies | Wholesalers | Consumer Protection | Division of Consumer Affairs | Press Release | Proposed Rules | Protecting New Jersey in Court

Advancing the Murphy Administration’s efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs (“Division”) announced specially adopted new rules promoting greater transparency in prescription drug pricing.